Results 201 to 210 of about 89,631 (313)

Hypoalbuminemia as a prognostic marker for survival in biliary tract cancer: associations with tumor type, treatment and sex. [PDF]

J Cancer Res Clin Oncol
Abdulrazzak M, Björkhem-Bergman L, Villard C, Gerling M, Gustavell T, Jansson H.   +5 more
europepmc   +1 more source

Genetically predicted KIR2DS4 mediate the association between gut microbe K10 and osteoporosis fractures: A mediation Mendelian randomization study

PM&R, EarlyView.
Abstract Background Osteoporosis fractures pose a significant public health concern, leading to substantial morbidity and mortality rates. The emerging evidence on the potential link between gut microbiota, proteins, and osteoporosis fractures suggests a complex relationship that warrants further investigation.
Qiong Wang, Qing Kuang, Cheng Chen, Binru Wang, Wei Xiang, Xinming Li, Jianjiao Mou   +6 more
wiley   +1 more source

Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions. [PDF]

J Clin Med
Jung JH, Lee KJ, Park SW, Koh DH, Lee J.
europepmc   +1 more source

Conservation status of species used in the UK herbal medicine industry

PLANTS, PEOPLE, PLANET, EarlyView.
Given the ongoing biodiversity crisis, sustainable use and management of medicinal plants is critical. We assessed the conservation status, threats and conservation actions of 298 species sold by UK suppliers to medical herbalists. We found that most species used are unevaluated, representing a gap in conservation knowledge, and of those with ...
Isabella Flowers, Jon C. Lovett, Christopher Hassall   +2 more
wiley   +1 more source

Biliary microbiota in disease-free, obstructive and post-drainage biliary tracts. [PDF]

Front Cell Infect Microbiol
Zhang G, Zeng L, Chen B, Dai H, Tang K, Huang R, Xiang X, Yang J, Yang J, Song X, Ma Y, Lin R, Huang Y.   +12 more
europepmc   +1 more source

Tumors of the liver [PDF]

, 1995
Iwatsuki, S, Starzl, TE
core  

Analysis of C4 Concentrations to Predict Impact of Patient‐Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 596-605, March 2025.
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño, Rashmi Mehta, Andrea Ribeiro de Souza, Jon Collins, Brandon Swift   +4 more
wiley   +1 more source

Intravenous Cholangiography in Biliary Tract Disease *

Annals of Surgery, 1960
G, JOHNSON, C, PEARCE, F, GLENN
openaire   +3 more sources

Biliary ascariasis without cholangitis: an unusual presentation in an endemic region. [PDF]

Oxf Med Case Reports
Nabil, Zohaib MA, Zubair M, Shafique U, Iqbal J, Hussain A.   +5 more
europepmc   +1 more source

Sclerosing cholangitis: Liver transplantation [PDF]

, 1989
Marsh, JW, Starzl, TE
core